Dungan KM - Search Results

1

Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.

Dungan KM, Buse JB, Herman WH, Arakaki RF, Jiang HH, Jacobson JG, Fahrbach JL. Dungan KM, et al. Diabetes Res Clin Pract. 2012 Jun;96(3):e66-9. doi: 10.1016/j.diabres.2012.02.005. Epub 2012 Mar 14. Diabetes Res Clin Pract. 2012. PMID: 22421598

2

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.

Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S. Dungan KM, et al. Diabetes Care. 2006 Jun;29(6):1214-9. doi: 10.2337/dc06-1910. Diabetes Care. 2006. PMID: 16731998

3

Glucose measurement: confounding issues in setting targets for inpatient management.

Dungan K, Chapman J, Braithwaite SS, Buse J. Dungan K, et al. Diabetes Care. 2007 Feb;30(2):403-9. doi: 10.2337/dc06-1679. Diabetes Care. 2007. PMID: 17259520 Review. No abstract available.

4

A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes.

Dungan KM, Guster T, DeWalt DA, Buse JB. Dungan KM, et al. Curr Med Res Opin. 2007 Nov;23(11):2689-95. doi: 10.1185/030079907x233304. Curr Med Res Opin. 2007. PMID: 17892636

5

1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.

Dungan KM. Dungan KM. Expert Rev Mol Diagn. 2008 Jan;8(1):9-19. doi: 10.1586/14737159.8.1.9. Expert Rev Mol Diagn. 2008. PMID: 18088226 Review.

6

Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S. Herman WH, et al. Among authors: dungan km. J Clin Endocrinol Metab. 2009 May;94(5):1689-94. doi: 10.1210/jc.2008-1940. Epub 2009 Mar 10. J Clin Endocrinol Metab. 2009. PMID: 19276235

7

Clinical experience with continuous glucose monitoring in adults.

Fabiato K, Buse J, Duclos M, Largay J, Izlar C, O'Connell T, Stallings J, Dungan K. Fabiato K, et al. Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S93-S103. doi: 10.1089/dia.2009.0004. Diabetes Technol Ther. 2009. PMID: 19469683

8

Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).

Dungan KM, Buse JB, Ratner RE. Dungan KM, et al. Diabetes Metab Res Rev. 2009 Sep;25(6):558-65. doi: 10.1002/dmrr.999. Diabetes Metab Res Rev. 2009. PMID: 19626663 Clinical Trial.

9

Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy.

Herman WH, Buse JB, Arakaki RF, Dungan KM, Jiang HH, Jacobson JG, Fahrbach JL. Herman WH, et al. Among authors: dungan km. Endocr Pract. 2011 Jul-Aug;17(4):563-7. doi: 10.4158/EP10348.OR. Endocr Pract. 2011. PMID: 21550959 Clinical Trial.

10

Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin.

Dungan K, Hall C, Schuster D, Osei K. Dungan K, et al. Diabetes Obes Metab. 2011 Dec;13(12):1130-5. doi: 10.1111/j.1463-1326.2011.01474.x. Diabetes Obes Metab. 2011. PMID: 21767340 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters